2021 Virtual Grand Rounds
Session 4

About
Faculty
Learning Objectives
Intended Audience
Accreditation Statement
Credit Designation Statement
Disclosure
Disclaimer

The Fall Clinical Virtual Grand Rounds 2021 series consists of weekly CME sessions on a variety of dermatological diseases and tools, delivered by the top experts in dermatology.

Please join us for this week's session:
Wednesday, March 3, 2021
8 PM EST/ 5 PM PST

COVID-19 Update and What It Means for Dermatology

Non-Surgical Treatment of Non-Melanoma Skin Cancer

Neal Bhatia, MD

Faculty

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, California

Stephen Tyring, MD, PhD

Faculty

Clinical Professor/ Medical Director
University of Texas Health Science Center, Center for Clinical Studies
Houston, TX

Upon completion of this activity, the participant should be better able to:

Discuss the implications of COVID-19 on our patients and employees and how to prevent transmission
Examine the application of new therapies and advances for treating actinic keratoses and non-melanoma skin cancer

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONFLICTS OF INTEREST/DISCLOSURES

Neal D. Bhatia, MD
Consultant: Almirall, Biofrontera, BMS, Dermira, EPI Health, Ferndale, Galderma, Incyte, ISDIN, J&J, LaRoche Posay, LEO, Mayne, Ortho Dermatologics, Sanofi Genzyme Regeneron, SUN, Vyne.
Grant/Research Support: Almirall, Biofrontera, BMS, EPI Health, Ferndale, Galderma, Incyte, ISDIN, L&J, LaRoche Posay, LEO, Mayne, Ortho Dermatologics, Pfizer, Sanofi Genzyme Regeneron, SUN, Vyne

Stephen K. Tyring, MD, PhD
Advisory Boards: BMS, Galderma, LEO
Consultant: BMS, Galderma, LEO
Grant/Research Support: Abbvie, Almirall, Amgen, BMS, Boheringer-Ingelheim, Janssen, LEO, Pfizer, SUN.
Speaker's Bureau: Abbvie, Amgen, Galderma, Janssen, LEO, Pfizer, Regeneron, SUN.

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

[fc+373]

2021 Virtual Grand Rounds Session 4